scispace - formally typeset
W

Wen Hua Lu

Researcher at Sun Yat-sen University

Publications -  5
Citations -  349

Wen Hua Lu is an academic researcher from Sun Yat-sen University. The author has contributed to research in topics: Cancer & Pancreatic cancer. The author has an hindex of 5, co-authored 5 publications receiving 260 citations.

Papers
More filters
Journal ArticleDOI

Xc− inhibitor sulfasalazine sensitizes colorectal cancer to cisplatin by a GSH-dependent mechanism

TL;DR: Results suggest that SSZ, a relatively non-toxic drug that targets cystine transporter, may, in combination with CDDP, have effective therapy for colorectal cancer.
Journal ArticleDOI

Micro-RNA-155 is induced by K-Ras oncogenic signal and promotes ROS stress in pancreatic cancer.

TL;DR: It is proposed that miR-155 plays an important role in oncogenic K-Ras transformation mediated by cellular redox regulation.
Journal ArticleDOI

ITD mutation in FLT3 tyrosine kinase promotes Warburg effect and renders therapeutic sensitivity to glycolytic inhibition.

TL;DR: It is reported that FLT3/ITD causes a significant increase in aerobic glycolysis through AKT-mediated upregulation of mitochondrial hexokinase (HK2), and renders the leukemia cells highly dependent on gly colysis and sensitive to pharmacological inhibition of glycoleytic activity.
Journal ArticleDOI

Decreased expression of the mitochondrial metabolic enzyme aconitase (ACO2) is associated with poor prognosis in gastric cancer

TL;DR: The results showed that the expression of ACO2 was significantly down-regulated in gastric cancer tissues compared with matched adjacent non-tumorous tissues and was associated with clinical stage and patients with lower ACO1 expression had a shorter survival time.
Journal ArticleDOI

Selective killing of K-ras –transformed pancreatic cancer cells by targeting NAD(P)H oxidase

TL;DR: This study provides a basis for developing a novel therapeutic strategy to effectively kill K-ras–transformed cells through a redox-mediated mechanism and abnormal ROS stress can selectively kill tumor cells by using NOX inhibitors.